| Julie O'keefe, MD | |
|
985 Prince Frederick Blvd Ste 201, Prince Frederick, MD 20678-3492 | |
| (410) 535-2005 | |
| (410) 535-4850 |
| Full Name | Julie O'keefe |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 36 Years |
| Location | 985 Prince Frederick Blvd Ste 201, Prince Frederick, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013078880 | NPI | - | NPPES |
| 4461101 | Other | MD | AETNA NON HMO PCP |
| 450892 | Other | MD | OPTIMUM CH MDIPA SPECIAL |
| 54587601 | Other | MD | CAREFIRST MD SPECIALIST |
| 54587602 | Other | MD | CAREFIRST MD PCP |
| C0410022 | Other | DC | CAREFIRST OF DC |
| 850892 | Other | MD | OPTIMUM CH MDIPA PCP |
| 2148224 | Other | MD | AETNA HMO PCP |
| 2154481 | Other | MD | AETNA HMO SPECIALIST |
| 325477100 | Medicaid | MD | |
| 110146724 | Other | MD | RAILROAD MEDICARE |
| 7720001 | Other | MD | AETNA NON HMO SPECIALIST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | D52192 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Calverthealth Medical Center | Prince frederick, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Calvert Internal Medicine Group, Pa | 1759371834 | 33 |
News Archive
A small pool of stem cells replenishes the human body with about 200 billion new blood cells daily. But the elaborate circuitry that determines if a cell will develop into a T cell, red blood cell, or one of the nine or more other blood cell types remains largely unknown. A research team led by scientists from the Broad Institute and Brigham and Women's Hospital has taken a systematic approach to help decipher this circuitry, compiling a comprehensive catalog of the factors that determine a blood cell's fate.
A study conducted over the past 18 years has found differences between lead exposure effects in young Japanese boys versus girls.
Nalmefene (trade name Selincro) has been approved since February 2013 for people with alcohol dependence who currently drink a lot of alcohol, but who do not have physical withdrawal symptoms and who do not require immediate detoxification. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in this patient group.
Researchers at the University of Southampton have engineered cells with a 'built-in genetic circuit' that produces a molecule that inhibits the ability of tumours to survive and grow in their low oxygen environment.
The SPEDOC project will create the precursor to future devices for individualized diagnosis and monitoring of cancer therapy, which will allow the illness to be treated in earlier stages and at lower doses, reducing or preventing current secondary effects.
› Verified 3 days ago
| Entity Name | Calvert Internal Medicine Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174682298 PECOS PAC ID: 1759371834 Enrollment ID: O20040512001521 |
News Archive
A small pool of stem cells replenishes the human body with about 200 billion new blood cells daily. But the elaborate circuitry that determines if a cell will develop into a T cell, red blood cell, or one of the nine or more other blood cell types remains largely unknown. A research team led by scientists from the Broad Institute and Brigham and Women's Hospital has taken a systematic approach to help decipher this circuitry, compiling a comprehensive catalog of the factors that determine a blood cell's fate.
A study conducted over the past 18 years has found differences between lead exposure effects in young Japanese boys versus girls.
Nalmefene (trade name Selincro) has been approved since February 2013 for people with alcohol dependence who currently drink a lot of alcohol, but who do not have physical withdrawal symptoms and who do not require immediate detoxification. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in this patient group.
Researchers at the University of Southampton have engineered cells with a 'built-in genetic circuit' that produces a molecule that inhibits the ability of tumours to survive and grow in their low oxygen environment.
The SPEDOC project will create the precursor to future devices for individualized diagnosis and monitoring of cancer therapy, which will allow the illness to be treated in earlier stages and at lower doses, reducing or preventing current secondary effects.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julie O'keefe, MD 985 Prince Frederick Blvd Ste 201, Prince Frederick, MD 20678-3492 Ph: (410) 535-2005 | Julie O'keefe, MD 985 Prince Frederick Blvd Ste 201, Prince Frederick, MD 20678-3492 Ph: (410) 535-2005 |
News Archive
A small pool of stem cells replenishes the human body with about 200 billion new blood cells daily. But the elaborate circuitry that determines if a cell will develop into a T cell, red blood cell, or one of the nine or more other blood cell types remains largely unknown. A research team led by scientists from the Broad Institute and Brigham and Women's Hospital has taken a systematic approach to help decipher this circuitry, compiling a comprehensive catalog of the factors that determine a blood cell's fate.
A study conducted over the past 18 years has found differences between lead exposure effects in young Japanese boys versus girls.
Nalmefene (trade name Selincro) has been approved since February 2013 for people with alcohol dependence who currently drink a lot of alcohol, but who do not have physical withdrawal symptoms and who do not require immediate detoxification. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in this patient group.
Researchers at the University of Southampton have engineered cells with a 'built-in genetic circuit' that produces a molecule that inhibits the ability of tumours to survive and grow in their low oxygen environment.
The SPEDOC project will create the precursor to future devices for individualized diagnosis and monitoring of cancer therapy, which will allow the illness to be treated in earlier stages and at lower doses, reducing or preventing current secondary effects.
› Verified 3 days ago
Dr. Mark J Kushner, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 110 Hospital Rd Ste 310, Prince Frederick, MD 20678 Phone: 410-535-2005 Fax: 410-535-4850 | |
Dr. Jonathan Kim Fears, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 985 Prince Frederick Blvd Ste 201, Prince Frederick, MD 20678 Phone: 410-535-2005 Fax: 410-535-4850 | |
Cassius Diego Belfonte, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 110 Hospital Rd, Suite 306, Prince Frederick, MD 20678 Phone: 410-414-6559 Fax: 410-414-5332 | |
Dr. Bilal Ahmed, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 110 Hospital Rd, Suite 105, Prince Frederick, MD 20678 Phone: 410-414-9116 Fax: 410-414-9118 | |
Dr. Reena Mary Thomas, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 205 Steeple Chase Dr 307, Prince Frederick, MD 20678 Phone: 443-432-3020 Fax: 410-486-7178 | |
Dr. Joseph John Barth Iii, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 110 Hospital Rd Ste 310, Prince Frederick, MD 20678 Phone: 410-535-2005 Fax: 410-535-4850 |